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http://www.biomedcentral.com/1756-0500/7/281RESEARCH ARTICLE Open AccessLong-term risk of stroke after transient ischaemic
attack: a hospital-based validation of the
ABCD2 rule
Rose Galvin1*, Penka A Atanassova2, Nicola Motterlini1ˆ, Tom Fahey1 and Borislav D Dimitrov1,3Abstract
Background: The ABCD2 clinical prediction rule is a seven point summation of clinical factors independently
predictive of stroke risk. The purpose of this cohort study is to validate the ABCD2 rule in a Bulgarian hospital up to
three years after TIA.
Methods: All consecutive admissions to an emergency department with symptoms of a first TIA were included.
Baseline data and clinical examinations including the ABCD2 scores were documented by neurologists.
Discrimination and calibration performance was examined using ABCD2 cut-off scores of ≥3, ≥4 and ≥5 points,
consistent with the international guidelines. The Hosmer-Lemeshow test was used to examine calibration between
the observed and expected outcomes as predicted by ABCD2 score within the logistic regression analysis.
Results: Eighty-nine patients were enrolled to the study with a mean age of 63 years (+/− 12 years). Fifty-nine
percent (n = 53) of the study population was male. Seven strokes (7 · 8%) occurred within the first year and six
further strokes within the three-year follow-up period. There was no incident of stroke within the first 90 days after
TIA. The rule demonstrated good predictive (OR = 1 · 58, 95% CI 1 · 09-2 · 29) and discriminative performance
(AUCROC = 0 · 72, 95% CI 0 · 58-0 · 86), as well as a moderate calibration performance at three years.
Conclusion: This validation of the ABCD2 rule in a Bulgarian hospital demonstrates that the rule has good
predictive and discriminative performance at three years. The ABCD2 is quick to administer and may serve as a
useful tool to assist clinicians in the long-term management of individuals with TIA.
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Transient ischaemic attack (TIA) and thrombotic stroke
arise from identical aetiologies and a number of studies
show that TIAs carry a significant risk of subsequent
stroke [1]. A recent systematic review reported that the
seven day pooled stroke risk after TIA was 6 · 2% but
there was substantial heterogeneity between the primary
studies included in the review with risks ranging from
0% to 18 · 7% [2]. Likewise, conflicting results have been
reported in the literature on long-term risk of stroke and
mortality following TIA or minor stroke in population* Correspondence: rosegalvin@rcsi.ie
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unless otherwise stated.and hospital based cohort studies [3]. Several clinical
scales have been developed to improve stratification of
recurrent stroke risk [4]. Identifying high-risk patients
after TIA is important because timely assessment and
management of these patients is essential. The ABCD2
clinical prediction rule (CPR) was derived in 2007 to as-
sist clinicians with the most appropriate management of
individuals with TIA [5]. The ABCD2 rule is a seven
point summation of clinical factors independently pre-
dictive of stroke risk. These factors include age, clinical
features such as motor impairment and speech disturb-
ance, duration of symptoms, history of diabetes and
hypertension. The rule identifies three strata of stroke
risk after TIA; low risk (0–3 points), moderate risk (4–5
points) and high risk (6–7 points) [5]. The ABCD2 rule
has been recommended for use in the management oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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A summary of the rule is displayed in Figure 1.
The ABCD2 score was derived and validated to pre-
dict risk of stroke up to 90 days after TIA in specialist
clinic cohorts and emergency departments (ED) from
Oxfordshire in the UK and from California, USA [5,10].
A number of studies have validated the rule for pre-
dicting short term risk of stroke after TIA and reported
inconsistent results, ranging from excellent predictive
value to little better than chance, largely due to the var-
ied methodological approaches. However, the evidence
from two recent systematic reviews demonstrates that
the rule has good predictive and discriminative accuracy
up to 90 days after stroke [2,10]. More recently, studies
have attempted to validate the rule to predict long term
risk of stroke after TIA [11-13]. While these studies have
reported that the rule has moderate predictive and dis-
criminative ability, the widespread applicability of the
ABCD2 score to predict long-term risk of stroke after
TIA depends on its consistency of performance in differ-
ent studies and settings [10]. Therefore, further broad
validation studies by investigators from different special-
ties and healthcare settings are necessary. This is the
first broad validation study that examines the long term
predictive value of the ABCD2 rule in a Bulgarian cohort
of patients admitted to ED after a TIA.Age - ≥ 60 years (1 point)
BP - systolic >140 mm Hg or diastolic >90 m
weakness (1 point)
Duration of symptoms - ≥60 minutes (2 point
Diabetes (1 point)
0-3 points 4-5 po
Low risk Moderat
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Figure 1 Summary of the ABCD2 score.Methods
Study design and setting
The Plovdiv project is a hospital-based cohort study
from 2002–2005, designed to determine predictors of
incidence and prognosis of major vascular events in-
cluding the recurrence of cerebrovascular or cardiovas-
cular events. The protocol for this project is described
in detail elsewhere [14,15]. Our study represents a sec-
ondary analysis of data collected from a prospective co-
hort of consecutive patients, presenting with symptoms
of TIA to the emergency department at the University
Hospital, Medical University of Plovdiv, Bulgaria. The
STROBE standardized reporting guidelines were fol-
lowed to report the findings of the study. Ethical ap-
proval was obtained from the Medical University of
Plovdiv ethics committee.
Study population
Patients were included in this study if they presented to
the emergency department with symptoms of a first
TIA, were aged >40 years and resident in Plovdiv. Con-
secutive TIA patients were registered prospectively.
Baseline data and the clinical examinations, including
those contained in the ABCD2 score, were documented
by the study neurologists at the recruitment of patients.
Determination of the ABCD2 risk score was performedm Hg (1 point)
s), 10–59 minutes(1 point)
ints 6-7 points
e risk High risk
nts), speech impairment without unilateral
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All patients underwent a CT or MRI scan to determine
the index event. Patients with a clinical diagnosis other
than TIA, or who were unwilling to give informed con-
sent were excluded from the study.
Outcomes
The TIA, as index event, was defined as a focal neuro-
logical deficit, clearly related to one of the main vascular
territories, lasting from few minutes up to 24 hours and
resolving completely within 24 hours, without evidence
of a recent infarction on a CT scan or MRI scan of the
brain [16]. Our primary outcome was the occurrence
of stroke at three years after TIA. However, in-keeping
with other studies of that have reported the short-term
predictive value of the rule, we also examined the inci-
dence of stroke at seven and 90 days also. A subsequent
stroke was defined using the World Health Organization
(WHO) definition of a clinical syndrome consisting of
‘rapidly developing clinical signs of focal (at times global)
disturbance of cerebral function lasting more than 24
hours or leading to death with no apparent cause other
than that of vascular origin’ and this definition was used
for our study [17]. All strokes were assessed by MRI or
CT scan and confirmed by a study neurologist. The de-
termination of the outcome endpoint was done when
blinded to the ABCD2 score and its variables. In terms
of patient follow-up, evaluations were conducted by the
study physicians during hospital visits every three months
for the first year and then annually for 36 months. Every
evaluation was carried out by contact with the patient and
where relevant with the family member or caregiver.
Statistical analysis
Descriptive statistics including means and standard devi-
ations were computed for baseline data. We examined
two aspects of validity of our results, discrimination and
calibration. Discrimination refers to the ability of ABCD2
score to distinguish correctly the patients with different
outcomes (stroke/no stroke). Logistic regression, Cox re-
gression with cumulative hazard function, and receiver
operation characteristics (ROC) curves with 95% confi-
dence intervals (95% CI) were used for the analysis. The
dependent variable was binary (stroke/no stroke) and
the predictor variables examined were the range of scores
on the ABCD2 rule. In addition, 2×2 cross-tables were
used to calculate discriminative accuracy (sensitivity and
specificity) at ≥3, ≥4 and ≥5 points on the ABCD2 rule.
These different cut-points are used to identify people at
low and high risk of stroke following TIA in several inter-
national guidelines on the management of patients with
TIA. The c statistic, or area under the curve (AUC), with
95% CI were also estimated to describe model discrimin-
ation. The c statistic ranges from 0 · 5 (no discrimination)to a theoretical maximum of 1, values between 0 · 7 and
0 · 9 represent moderate accuracy and greater than 0 · 9
represents high accuracy [18]. A c statistic of 1 represents
perfect discrimination, whereby scores for all cases with
stroke are higher than those for all the non-cases with no
overlap.
Calibration (or reliability) reflects how closely pre-
dicted outcomes agree with the actual outcomes. For
this purpose, the Hosmer-Lemeshow test (HLT) was
used for comparison between the observed outcomes
and those expected as predicted by ABCD2 score within
the logistic regression analysis. We also used the fre-
quency distribution patterns in the initial derivation
study of the ABCD2 rule as a predictive model against
which our validation study was compared. Therefore the
predicted number of patients with stroke at seven and
90 days (based on the probability calculated in the deriv-
ation study) was compared with the observed number of
patients with stroke from our validation study. All tests
were two sided. An association was considered signifi-
cant at p < 0 · 05. All statistical analyses were completed
using STATA (version 12, Stata Corp, College Station,
Texas, USA) and IBM SPSS Statistics (Ver.21, IBM
Corporation, USA).
Results
Demographics
From January 2002 to December 2005, a total of 98
patients with a confirmed TIA were deemed eligible for
inclusion to the study. Eighty-nine patients provided
written informed consent. The time from onset of symp-
toms to enrollment was less than 12 hours in all cases.
The mean age of patients was 63 years (±12 years). Fifty-
nine percent (n = 53) of the cohort was male. Baseline
characteristics of enrolled patients are presented in Table 1.
All patients were followed up during the study period.
There were 13 subsequent strokes observed in the cohort
of patients, representing an overall stroke rate of 14 · 6% at
three years. There was no incident of stroke within the
first seven or 90 days after TIA. Seven strokes (7 · 8%) oc-
curred within the first year and six further strokes within
the 3-year follow-up period. The stroke specific mortality
rate was 4 · 5% (n = 4) and all cause mortality was 10 · 1%
(n = 9) at three years.
Discrimination
The one year and three year incidence of stroke strati-
fied according to ABCD2 score (≥3, ≥4 and ≥5 points) is
presented in Table 2. The logistic regression analysis in-
dicates that the ABCD2 score is a significant predictor
of stroke at one year (OR = 1 · 79, 95% CI 1 · 05-3 · 08,
p = 0 · 03) and three years (OR = 1 · 58, 95% CI 1 · 09-2 · 29,
p = 0 · 02), indicating that on average, a one point increase
in the ABCD2 score may lead to a 58% increase in the
Table 1 Baseline characteristics of patients with TIA
Patient characteristics Parameters*
Age (years) 63 (±12)
Gender (male) 53 (59.5%)
Systolic BP (mmHg) 152 (±23)
Diastolic BP(mmHg) 91 (±15)
Hypertension 66 (74.2%)
Clinical features
Unilateral weakness 43 (48.3%)
Speech disturbance without weakness 10 (11.2%)
Duration of symptoms (minutes)
≥60 29 (32.6%)
10-59 44 (49.4%)
<10 16 (18%)
Diabetes 19 (21.3%)
Time from onset to enrollment (hours) < 12
History of:
Smoking 38 (42.7%)
Atrial fibrillation 2 (2.2%)
Angina 15 (16.9%)
High cholesterol 6 (6.7%)
Anti-platelet therapy 6 (6.7%)
Statins 0 (0%)
*Note: Mean (±SD) or number (percent), as appropriate.
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as a significant predictor is further confirmed by the Cox
regression model showing that the baseline cumulative
hazard of 0 · 02 is expected to increase to 0 · 13 when the
mean ABCD2 score is taken into account (Figure 2). The
hazard function provides narrower, time-adjusted esti-
mates of the confidence interval of the expected stroke
risk of 1 · 57, from 1 · 12 to 2 · 21.
The overall discriminative performance of the ABCD2
rule at three years is also confirmed by the ROC curve
analysis (Figure 3) indicating about 72% overall accu-
racy by a significant area under the curve at p < 0 · 013
(AUCROC = 0 · 72, 95% CI 0 · 58-0 · 86). Higher estimates
of discriminative performance were found at one yearTable 2 The incidence of stroke up to three years
stratified according to the ABCD2 score
Variable ABCD2 score
0 1 2 3 4 5 6 7
All patients (n = 89) 4 8 16 12 17 12 15 5
Stroke within 7 days 0 0 0 0 0 0 0 0
Stroke within 90 days 0 0 0 0 0 0 0 0
Stroke within 1 year 0 0 0 1 1 1 3 1
Stroke within 3 years 0 0 1 1 1 0 3 0(AUCROC = 0 · 76, 95% CI 0 · 66-0 · 85). The specific indi-
cators of discriminative performance at one and three
years are displayed as summary estimates of sensitivity
and specificity and AUCs for the different cut-off scores
(Table 3). At one year following stroke, the ABCD2 rule
is more useful at ruling out stroke in those classified as
low risk using all three cut-points, with a greater sum-
mary estimates of sensitivity than specificity. The results
are broadly similar at three years.
Calibration
At three years, the analysis of the overall calibration per-
formance indicates that there is no statistically signi-
ficant difference between the observed and expected
outcomes as predicted by the ABCD2 rule (χ2 HLT = 4.11,
p = 0 · 533). When further using the original derivation
study as a short-term predictive model, the ABCD2 rule
tends to over-predict the risk of stroke at seven days
across all three original risk strata: low risk, [RR 3 · 00,
95% CI (0 · 13-71 · 51)]; intermediate risk, [(RR 5 · 00,
95% CI (0 · 25-99 · 82)]; and high risk, [(RR 4 · 33, 95% CI
(0 · 75-24 · 90)]. The results are broadly similar at 90 days
across all three risk strata: low risk, [RR 3 · 00, 95% CI
(0 · 13-71 · 51)]; intermediate risk, [(RR 5 · 00, 95%
CI (0 · 25-99 · 82)]; and high risk, [(RR 9 · 00, 95% CI
(0 · 52-156 · 91)]. There are seven strokes predicted at
90 days when using the original derivation study as a
predictive model but no incident of stroke was observed
in our dataset within this time across all three risk strata
of risk.
Discussion
Statement of principal findings
This broad validation of the ABCD2 clinical prediction
rule in Bulgarian patients demonstrates that the rule has
a good predictive and discriminative performance, as
well as a moderate calibration performance at three years.
The results also indicate that the rule over-predicts the
risk of stroke at seven and 90 days in comparison with the
frequency distributions patterns from the original deri-
vation study.
Results in the context of the current literature
Our findings are broadly in-keeping with two other
retrospective studies that have examined the long term
predictive value of the ABCD2 rule [11,12]. In our study,
7 · 8% of patients had a stroke within the first year
and six further strokes occurred within the three year
follow-up period (14 · 94%). These results are similar to a
German multi-centre hospital based validation of the
ABCD2 rule where the overall risk of stroke at one year
was estimated at 6 · 5% in a cohort of 1448 patients [3].
Our findings are also in keeping with a retrospective
study by Harrison and colleagues who, although not
Figure 2 Cumulative curve illustrating the increasing risk of stroke within 3 years of TIA.
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overall absolute risk of stroke in patients who attended
an outpatient clinic with a TIA was 7 · 3% within one
year, 16 · 2% within five years and 28 · 0% within ten
years [12]. Similar to our study, patients with higher
ABCD2 scores (≥3 points) experienced higher stroke risk
within one year and this risk persisted at five and ten
years [12].
A recent systematic review of studies that validated
the ABCD2 rule reported a low overall rate of stroke at
seven days (1 · 72%) and 90 days (2 · 63%) in patients iden-
tified as low risk using an ABCD2 score of 0–3 points [2].Figure 3 Discriminative performance of ABCD2 score within 3 years oFurthermore, these patients represented one third of the
overall cohort of patients in the meta-analysis [2]. Almost
45% of individuals in our dataset were classified as low
risk using the ABCD2 cut-off score and there was no in-
cident of stroke in this patient group within seven or
90 days. This finding in not surprising given the low
stroke rate reported in the pooled analysis of studies. In
addition, our results are similar to three other hospital
based validation studies where no event of stroke was re-
corded in the low risk group at seven days [19-21]. While
we reported no incident of stroke across all three strata of
risk at seven or 90 days, a study by Coutts and colleaguesf TIA.
Table 3 Discriminative value of the ABCD2 rule to identify patients at high risk of stroke at one and three years
Patients at high risk of stroke (as per international guidelines) Discrimination (95% confidence interval)
ABCD2 ≥ 3 (US guidelines) Sensitivity Specificity Area under curve
1 year 1.00 (0.59 - 1.00) 0.34 (0.24 - 0.45) 0.67 (0.62 – 0.72)
3 years 0.92 (0.64 - 1.00) 0.36 (0.25 - 0.47) 0.64 (0.55 – 0.73)
ABCD2 ≥ 4 (UK & New Zealand guidelines)
1 year 0.86 (0.42 - 1.00) 0.48 (0.36 - 0.59) 0.67 (0.55 – 0.76)
3 years 0.77 (0.46 - 0.95) 0.49 (0.37 - 0.60) 0.63 (0.50 – 0.76)
ABCD2 ≥ 5 (Australian guidelines)
1 year 0.71 (0.29 - 0.96) 0.67 (0.56 - 0.77) 0.69 (0.51 – 0.88)
3 years 0.62 (0.32 - 0.86) 0.68 (0.57 - 0.79) 0.65 (0.50 – 0.80)
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groups at seven or 90 days in a cohort of 87 patients [20].
However, our results need to be interpreted with caution
due to the large number of patients in the low risk cat-
egory and limited sampled population included in the val-
idation study.
The overall discriminative value of the ABCD2 score at
three years is significantly better than chance, as mea-
sured by ROC area under the curve and associated 95%
CIs being above the null value of 0 · 5. While no other
study has examined the discriminative performance of
the rule at three years, the accuracy of the rule has been
examined up to 13 · 8 years and an acceptable level of
accuracy by AUC of 0 · 630 (95% CI 0 · 58-0 · 67) was re-
ported [12]. Our results are also similar to those re-
ported in a systematic review of the discriminative
accuracy of the ABCD2 at seven days [AUC 0 · 72 (95%
CI 0 · 63-0 · 82)] [10], suggesting that the rule has reason-
able ability to correctly distinguish patients with and
without stroke at three years.
Strengths and weaknesses of the study
This is the first broad hospital based validation study to
examine the predictive and discriminative value of the
ABCD2 score in a Bulgarian cohort up to three years
after TIA. The risk of stroke is presented in risk strata
consistent with those applied in the international guide-
lines on the management of stroke so that the value of
the ABCD2 score across these strata can be interpreted
in a clinically meaningful way. Furthermore, the ABCD2
rule was applied to our cohort of patients according to
the methods described by original developers [5]. Our
method of calibration analysis further examines the spe-
cific performance ability of the rule by using the ratio of
predicted stroke (from the original derivation study) to
observed stroke in the present validation study. How-
ever, the generalisability of our results may be influenced
to some extent by the relatively limited number of the
patients included in our study. The comparability of ourfindings to the current literature is restricted by the lim-
ited number of studies that examine the long-term dis-
criminative performance of the ABCD2. Therefore there
is a need for future large multi-centre cohort studies
to examine the long term predictive value of the rule
in different clinical settings. The impact of the rule in
the ED setting also warrants further investigation, par-
ticularly in terms of patient outcome, clinician behaviour,
cost effectiveness and resource use, or any combination
of these.Clinical and policy implications
Current international guidelines recommend that indi-
viduals with low ABCD2 scores should be triaged for
specialist assessment within one week of onset of symp-
toms. While we observed no incident of stroke in our
patients with ABCD2 score of 0–3 points at seven days,
it is worth noting that the overall stroke rate in these pa-
tients was 7 · 5% within three years. Therefore, even at a
lower risk initially, there is a need for a regular review of
these specific patients in the primary care or specialist
setting to monitor and manage their ongoing cerebro-
vascular risk and minimise the risk of subsequent stroke
or other related cardiovascular events.
There is a lack of consistency in the international
guidelines on what constitutes a ‘low’ and ‘high’ risk pa-
tient and we have reported our data accordingly. All
guidelines relating to the management of individuals
classified as ‘high risk’ include early neurology consult-
ation to confirm the diagnosis of TIA, rapid diagnostic
assessment, and implementation of aetiology-specific
precautionary measures, including carotid endarterec-
tomy and anticoagulation [2]. However, there is a need
for consensus in relation to the identification of indi-
viduals at high risk of subsequent stroke as the var-
ious cut-points of ABCD2 score used to categorise
stroke risk have considerable economic and manage-
ment implications.
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This validation of the ABCD2 rule in a Bulgarian hospital
setting demonstrates that the rule has a good predictive
and discriminative performance at three years. The results
also indicate that the rule tends to over-predict the risk of
stroke at seven and 90 days in comparison with the fre-
quency distributions patterns from the original derivation
study. The ABCD2 is easy and quick to administer and it
is a useful tool to assist clinicians in the long term ma-
nagement of individuals with TIA.
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